| MeSH term | MeSH ID | Detail |
|---|---|---|
| Drug Hypersensitivity | D004342 | 20 associated lipids |
| Tuberculosis, Pulmonary | D014397 | 18 associated lipids |
| Peritoneal Neoplasms | D010534 | 16 associated lipids |
| Liver Diseases, Alcoholic | D008108 | 13 associated lipids |
| Hypercalcemia | D006934 | 13 associated lipids |
| Vitamin D Deficiency | D014808 | 13 associated lipids |
| Critical Illness | D016638 | 13 associated lipids |
| Carbon Tetrachloride Poisoning | D002252 | 12 associated lipids |
| Hypocalcemia | D006996 | 12 associated lipids |
| Hepatitis | D006505 | 11 associated lipids |
Glucaric acid
Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.
Cross Reference
Introduction
To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Glucaric acid?
Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Glucaric acid
PubChem Associated disorders and diseases
What pathways are associated with Glucaric acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Glucaric acid?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Glucaric acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Glucaric acid?
There are no associated biomedical information in the current reference collection.
What genes are associated with Glucaric acid?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Glucaric acid?
Knock-out
Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Glucaric acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| MacNeil ML et al. | A semiautomated procedure for urinary D-glucaric acid using a centrifugal analyzer. | 1986 Jan-Feb | J Anal Toxicol | pmid:3951202 |
| Silverberg DS et al. | Effect of correction of anemia with erythropoietin and intravenous iron in resistant heart failure in octogenarians. | 2003 | Isr. Med. Assoc. J. | pmid:12811950 |
| Pinsk V et al. | Efficacy and safety of intravenous iron sucrose therapy in a group of children with iron deficiency anemia. | 2008 | Isr. Med. Assoc. J. | pmid:18605353 |
| Kaplinsky C | Parenteral iron therapy. | 2008 | Isr. Med. Assoc. J. | pmid:18605363 |
| Herzberg M et al. | Hepatic microsomal enzyme induction and its evaluation in a clinical laboratory. | 1977 | Isr. J. Med. Sci. | pmid:17578 |
| Heerdt AS et al. | Calcium glucarate as a chemopreventive agent in breast cancer. | 1995 Feb-Mar | Isr. J. Med. Sci. | pmid:7744577 |
| Yamamoto S et al. | Fibroblast growth factor 23-related osteomalacia caused by the prolonged administration of saccharated ferric oxide. | 2012 | Intern. Med. | pmid:22975552 |
| Tampi R | Delayed adverse reactions to iron polymaltose and iron sucrose. | 2010 | Intern Med J | pmid:20446963 |
| Hanausek M et al. | Detoxifying cancer causing agents to prevent cancer. | 2003 | Integr Cancer Ther | pmid:15035900 |
| Yoshimi N et al. | Inhibition of azoxymethane-induced rat colon carcinogenesis by potassium hydrogen D-glucarate. | 2000 | Int. J. Oncol. | pmid:10601547 |
| Kowalczyk MC et al. | Effects of combined phytochemicals on skin tumorigenesis in SENCAR mice. | 2013 | Int. J. Oncol. | pmid:23835587 |
| Matsuo E et al. | Acid mucopolysaccharide metabolism in leprosy. 3. Hyaluronic acid mycobacterial growth enhancement, and growth suppression by saccharic acid and vitamin C as inhibitors of beta-glucuronidase. | 1975 Jan-Mar | Int. J. Lepr. Other Mycobact. Dis. | pmid:1099016 |
| Sasaki Y et al. | Hepcidin production in response to iron is controlled by monocyte-derived humoral factors. | 2014 | Int. J. Hematol. | pmid:24293278 |
| Asma S et al. | Safety, therapeutic effectiveness, and cost of parenteral iron therapy. | 2009 | Int. J. Hematol. | pmid:19495930 |
| Beck-da-Silva L et al. | IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia. | 2013 | Int. J. Cardiol. | pmid:23680589 |
| Toblli JE et al. | Cardiovascular outcomes of intravenous iron in perspective of clinical trials and the use of different iron preparations. | 2015 | Int. J. Cardiol. | pmid:25838213 |
| Beck-da-Silva L et al. | Iron therapy in patients with heart failure. A straight shot. | 2013 | Int. J. Cardiol. | pmid:23931974 |
| Strik JJ and de Wit JM | Health aspects of rabbits in a low-TCDD contaminated area. | 1980 | Int. J. Biochem. | pmid:7450162 |
| Pak KY et al. | Labeling and stability of radiolabeled antibody fragments by a direct 99mTc-labeling method. | 1992 | Int J Rad Appl Instrum B | pmid:1522021 |
| Arteaga de Murphy C et al. | 99mTc-glucarate for detection of isoproterenol-induced myocardial infarction in rats. | 2002 | Int J Pharm | pmid:11897407 |
| Shah RB et al. | Pharmaceutical characterization and thermodynamic stability assessment of a colloidal iron drug product: iron sucrose. | 2014 | Int J Pharm | pmid:24440404 |
| Wiśniewska-Knypl JM and Wrońska-Nofer T | Biological markers of oxidative stress induced by ethanol and iron overload in rat. | 1994 | Int J Occup Med Environ Health | pmid:7719662 |
| Aspuru K et al. | Optimal management of iron deficiency anemia due to poor dietary intake. | 2011 | Int J Gen Med | pmid:22114518 |
| Gachályi B et al. | Effect of alphamethyldopa on the half-lives of antipyrine, tolbutamide and D-glucaric acid excretion in man. | 1980 | Int J Clin Pharmacol Ther Toxicol | pmid:6103880 |
| Hajós P et al. | The effect of oral contraceptives on serum lipids gamma-glutamyl transpeptidase, and excretion of d-glucaric acid. | 1981 | Int J Clin Pharmacol Ther Toxicol | pmid:6112206 |
| Gachályi B et al. | Combined effect of alpha-methyldopa and a new enzyme inducer, Zixoryn, on the hepatic mixed-function monooxygenase system in humans. | 1983 | Int J Clin Pharmacol Ther Toxicol | pmid:6862721 |
| Németh I and Szeleczki T | Increased D-glucaric acid excretion in children with renal disease. | 1980 | Int J Clin Pharmacol Ther Toxicol | pmid:7409939 |
| Larousse C et al. | Tuberculosis therapy and enzyme induction in man. | 1980 | Int J Clin Pharmacol Ther Toxicol | pmid:7380590 |
| Perry W and Jenkins MV | Note on the enzyme assay for urinary D-glucaric acid and correlation with rifampicin-induced mixed function oxidase activity. | 1986 | Int J Clin Pharmacol Ther Toxicol | pmid:3793294 |
| Larousse C et al. | Research on the eventual enzymatic induction activity of cetiedil in rat and man. | 1980 | Int J Clin Pharmacol Ther Toxicol | pmid:7390670 |
| Gachályi B et al. | Effect of a non-steroid anti-inflammatory agent on the drug metabolizing activity of the human liver. | 1984 | Int J Clin Pharmacol Ther Toxicol | pmid:6469424 |
| Freundt KJ et al. | Concentrations of D-glucaric acid in human urine after repeated administration of pyrithioxine. | 1984 | Int J Clin Pharmacol Ther Toxicol | pmid:6526537 |
| Rost KL et al. | Urinary 6 beta-hydroxycortisol and D-glucaric acid excretion rates are not affected by lansoprazole treatment. | 1997 | Int J Clin Pharmacol Ther | pmid:9021436 |
| Vezekenyi Z et al. | Human tolerance of flumecinol (Zixoryn, RGH-3332), its regime and dosage in healthy volunteers. | 1983 | Int J Clin Pharmacol Res | pmid:6679516 |
| Traeger A et al. | Beta-adrenoceptor blocking drugs and cytochrome P-450: the influence of propranolol treatment on caffeine, antipyrine, D-glucaric acid and indocyanine green elimination in patients with hepatic disorders. | 1986 | Int J Clin Pharmacol Res | pmid:3744626 |
| Freundt KJ | Variable inhibition of human hepatic drug metabolizing enzymes by disulfiram. | 1978 | Int J Clin Pharmacol Biopharm | pmid:669879 |
| Freundt KJ | Production of endogenous D-glucaric acid and oxidative N-demethylation of amidopyrine in man: lack of correlation. | 1979 | Int J Clin Pharmacol Biopharm | pmid:429081 |
| Houin G and Tillement JP | Clofibrate and enzymatic induction in man. | 1978 | Int J Clin Pharmacol Biopharm | pmid:649234 |
| Chinnappa S and Bhandari S | Influence of intravenous iron therapy on novel markers of iron deficiency. | 2010 | Int J Artif Organs | pmid:20593351 |
| Døssing M | Noninvasive assessment of microsomal enzyme activity in occupational medicine: present state of knowledge and future perspectives. | 1984 | Int Arch Occup Environ Health | pmid:6142865 |
| Ferreira M et al. | Determinants of urinary thioethers, D-glucaric acid and mutagenicity after exposure to polycyclic aromatic hydrocarbons assessed by air monitoring and measurement of 1-hydroxypyrene in urine: a cross-sectional study in workers of coke and graphite-electrode-producing plants. | 1994 | Int Arch Occup Environ Health | pmid:8175189 |
| Pasquini R et al. | Urinary excretion of mutagens, thioethers and D-glucaric acid in workers exposed to bitumen fumes. | 1989 | Int Arch Occup Environ Health | pmid:2707871 |
| Kolmodin-Hedman B | Enzyme induction: its relevance for internal exposure and health risks. | 1988 | Int Arch Occup Environ Health | pmid:3049388 |
| Pasquini R et al. | Mutagenicity studies and D-glucaric acid determination in urine of workers exposed to mineral oils. | 1985 | Int Arch Occup Environ Health | pmid:3905625 |
| Edwards JW and Priestly BG | Effect of occupational exposure to aldrin on urinary D-glucaric acid, plasma dieldrin, and lymphocyte sister chromatid exchange. | 1994 | Int Arch Occup Environ Health | pmid:7843832 |
| Notten WR and Henderson PT | The interaction of chemical compounds with the functional state of the liver. II. Estimation of changes in D-glucaric acid synthesis as a method for diagnosing exposure to xenobiotics. | 1977 | Int Arch Occup Environ Health | pmid:832915 |
| Kato M et al. | Tetranuclear copper(II) complexes bridged by alpha-D-glucose-1-phosphate and incorporation of sugar acids through the Cu4 core structural changes. | 2006 | Inorg Chem | pmid:16903719 |
| Toblli JE et al. | Comparison of oxidative stress and inflammation induced by different intravenous iron sucrose similar preparations in a rat model. | 2012 | Inflamm Allergy Drug Targets | pmid:22309085 |
| Marre R et al. | Animal studies on the reduction of aminoglycoside-induced nephrotoxicity by D-glucaro-1,5-lactam. | 1983 May-Jun | Infection | pmid:6885175 |
| Yang Z et al. | Parasitic nematode-induced modulation of body weight and associated metabolic dysfunction in mouse models of obesity. | 2013 | Infect. Immun. | pmid:23509143 |